Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001437749-22-001271
Filing Date
2022-01-20
Accepted
2022-01-20 08:16:25
Documents
3

Document Format Files

Seq Description Document Type Size
1 FORM DEFA14A nby20220118_defa14a.htm DEFA14A 15715
2 letter01.jpg GRAPHIC 182268
3 letter02.jpg GRAPHIC 46136
  Complete submission text file 0001437749-22-001271.txt   331441
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

EIN.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-33678 | Film No.: 22540723
SIC: 2834 Pharmaceutical Preparations